Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Cheyenne Dairy No. 2
WARNING LETTER
•Cheyenne Dairy No. 2•January 14, 2008

Cheyenne Dairy No. 2 – FDA Warning Letter, Jan 14, 2008

Record Details

An FDA inspection of Cheyenne Dairy No. 2, owned by Mr. David A. Hoekstra, conducted from January 9-14, 2008, revealed significant violations concerning adulterated animals sold for slaughter and unsafe/adulterated new animal drug use. The inspection confirmed that animals offered for food were adulterated under sections 402(a)(2)(C)(ii) and 402(a)(4) of the Federal Food, Drug, and Cosmetic Act (the Act). Specifically, a cow sold on October 22, 2007, had Penicillin residues (0.61 ppm in kidney) exceeding the 0.05 ppm tolerance (21 CFR § 556.510). Another cow sold on September 28, 2007, showed Flunixin residues (0.611 ppm in liver, 0.038 ppm in muscle) exceeding tolerances (0.125 ppm liver, 0.025 ppm muscle) (21 CFR § 556.286).

The dairy also lacked an adequate system to ensure proper drug withdrawal times, leading to medicated animals with potentially harmful residues entering the food supply, and failed to maintain complete treatment records. Furthermore, the new animal drug Penicillin G Procaine Injectable Suspension U.S.P. was rendered unsafe and adulterated (sections 512(a) and 501(a)(5) of the Act) due to extralabel use not conforming to approved labeling. This included administering three times the recommended dose without licensed veterinarian supervision (21 C.F.R. § 530.11(a)) and resulting in illegal drug residues (21 C.F.R. § 530.11(d)). The FDA requires prompt corrective action and a written response within fifteen working days detailing steps taken to correct violations and prevent recurrence, including documentation. Failure to comply may lead to regulatory actions such as seizure or injunction.

Company
Cheyenne Dairy No. 2
Inspection date
January 14, 2008
Product type
Drugs
Office
Denver District Office
People
  • Ronald C. Nelson (Owner)
  • Miley Goinzalez (I.)
  • Thomas Warwick (H.)
View Company Profile

ID · e114b8bb-a76b-44a2-95f8-9bda3aaf1aae

Violation Codes10
21 U.S.C. 342(a)(2)(C)(ii)21 U.S.C. 342(a)(4)21 U.S.C. 360b(a)21 U.S.C. 351(a)(5)21 U.S.C. 360b(a)(4)21 U.S.C. 360b(a)(5)21 CFR 556.51021 CFR 556.28621 CFR 530.11(a)21 CFR 530.11(d)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Cheyenne Dairy No. 2
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.